These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 25341886)

  • 1. Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans.
    Madabhushi SR; Zhang C; Kelkar A; Dayananda KM; Neelamegham S
    J Am Heart Assoc; 2014 Oct; 3(5):e001420. PubMed ID: 25341886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physical spacing between the von Willebrand factor D'D3 and A1 domains regulates platelet adhesion in vitro and in vivo.
    Zhang C; Kelkar A; Nasirikenari M; Lau JTY; Sveinsson M; Sharma UC; Pokharel S; Neelamegham S
    J Thromb Haemost; 2018 Mar; 16(3):571-582. PubMed ID: 29251812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V.
    Ulrichts H; Udvardy M; Lenting PJ; Pareyn I; Vandeputte N; Vanhoorelbeke K; Deckmyn H
    J Biol Chem; 2006 Feb; 281(8):4699-707. PubMed ID: 16373331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear.
    Hrdinova J; Fernández DI; Ercig B; Tullemans BME; Suylen DPL; Agten SM; Jurk K; Hackeng TM; Vanhoorelbeke K; Voorberg J; Reutelingsperger CPM; Wichapong K; Heemskerk JWM; Nicolaes GAF
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor (VWF) propeptide binding to VWF D'D3 domain attenuates platelet activation and adhesion.
    Madabhushi SR; Shang C; Dayananda KM; Rittenhouse-Olson K; Murphy M; Ryan TE; Montgomery RR; Neelamegham S
    Blood; 2012 May; 119(20):4769-78. PubMed ID: 22452980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific electrostatic interactions between charged amino acid residues regulate binding of von Willebrand factor to blood platelets.
    Interlandi G; Yakovenko O; Tu AY; Harris J; Le J; Chen J; López JA; Thomas WE
    J Biol Chem; 2017 Nov; 292(45):18608-18617. PubMed ID: 28924049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
    Ju L; Dong JF; Cruz MA; Zhu C
    J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
    Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
    J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
    Martin C; Morales LD; Cruz MA
    J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
    Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
    J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual roles of fucoidan-GPIbα interaction in thrombosis and hemostasis: implications for drug development targeting GPIbα.
    Shen C; Mackeigan DT; Shoara AA; Xu R; Bhoria P; Karakas D; Ma W; Cerenzia E; Chen Z; Hoard B; Lin L; Lei X; Zhu G; Chen P; Johnson PE; Ni H
    J Thromb Haemost; 2023 May; 21(5):1274-1288. PubMed ID: 36732162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The functions of the A1A2A3 domains in von Willebrand factor include multimerin 1 binding.
    Parker DN; Tasneem S; Farndale RW; Bihan D; Sadler JE; Sebastian S; de Groot PG; Hayward CP
    Thromb Haemost; 2016 Jul; 116(1):87-95. PubMed ID: 27052467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desialylation of O-glycans activates von Willebrand factor by destabilizing its autoinhibitory module.
    Voos KM; Cao W; Arce NA; Legan ER; Wang Y; Shajahan A; Azadi P; Lollar P; Zhang XF; Li R
    J Thromb Haemost; 2022 Jan; 20(1):196-207. PubMed ID: 34529349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.
    Bonnefoy A; Yamamoto H; Thys C; Kito M; Vermylen J; Hoylaerts MF
    Blood; 2003 Feb; 101(4):1375-83. PubMed ID: 12393553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor self-association on platelet GpIbalpha under hydrodynamic shear: effect on shear-induced platelet activation.
    Dayananda KM; Singh I; Mondal N; Neelamegham S
    Blood; 2010 Nov; 116(19):3990-8. PubMed ID: 20696943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events.
    Gardiner EE; Arthur JF; Shen Y; Karunakaran D; Moore LA; Am Esch JS; Andrews RK; Berndt MC
    Platelets; 2010; 21(4):244-52. PubMed ID: 20367574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein (GP) Ib-IX-transfected cells roll on a von Willebrand factor matrix under flow. Importance of the GPib/actin-binding protein (ABP-280) interaction in maintaining adhesion under high shear.
    Cranmer SL; Ulsemer P; Cooke BM; Salem HH; de la Salle C; Lanza F; Jackson SP
    J Biol Chem; 1999 Mar; 274(10):6097-106. PubMed ID: 10037692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.